CC BY
27
ВНУТРЕННИЕ БОЛЕЗНИ
INTERNAL MEDICINE
УДК 614.39-613.24
S.T. ALLIYAROVA
S.D. Asfendiyarov Kazakh National medical university, Almaty, Kazakhstan
ECONOMIC AND SOCIAL CONSEQUENCES OF OBESITY
The article presents literature data about the relevance and prevalence of obesity and also considered the socio-economic factors contributing to obesity.
Keywords: arterial hypertension, WHO, obesity, overweight, BMI
Introduction. Obesity is a pathological condition that has social and economic importance, since it covers a large part of the population in some developing countries.
In 1950, obesity was included to the International Classification of Diseases of the World Health Organization (WHO), the main criterion for the diagnosis of which was the body mass index (BMI). According to the WHO classification of 2004 BMI in the range of 18.5 to 24.9 kg / m2 is considered normal, BMI below 18.5 kg / m2 is considered as underweight; overweight defined as BMI of 25,00-29,99 kg / m2; BMI of 30-40 kg / m2 indicates obesity and finally BMI that above 40 kg / m2 allows us to speak about the "painful (morbidity)" obesity [1].
The main factor leading to the development of obesity, is a violation of the energy balance, the discrepancy between the energy flow in the body and their cost. The most common disease is caused by overeating, but may develop on the background of reduction of energy consumption [2]. Undoubted constitutional role on obesity play hereditary predisposition, age, sex, occupational factors, the nature of eating disorders, dysfunctions of the nervous and endocrine systems [3].
Of great importance in the development of obesity in diseases of the digestive system is not only a change of character, but also a violation of the diet, in particular rare food intakes and displacement of maximum calories to the evening hours when most active synthesis and deposition of fat takes place [4]. Health Risks Linked to Obesity. As noted in the report of the WHO in 2002, worldwide obesity affects more than a billion people, including clinical obesity that present in 300 million people. In this risk group at least 500 thousand people die every year [5].
Obesity may be complicated by cardio - vascular diseases (CVD), diabetes (C), cancer, respiratory diseases, gallstones and other diseases. The accumulation of 4-5 kg excess fat in the body creates a dangerous shift in metabolism, which is enough to start the mechanism of the development of atherosclerosis [6]. In 2013 a meta-analysis of 97 prospective studies was published that carried out from 1948 to 2005, which shows that the risk of coronary heart disease (ischemic heart disease) is much higher with excessive BMI (> = 25 - <30 kg / m2) and obesity (BMI> = 30 kg / m2) (44% relative risk); the risk of stroke (acute ischemic stroke) above 98% for patients with overweight BMI and 69% for obesity (taking into account risk factors such as elevated levels of BP (blood pressure), cholesterol and glucose)
[7].
According to WHO, obesity caused by 44% of cases of diabetes (diabetes mellitus), 23% ischemic heart disease and 7-41% of certain types of cancer [8].
In 1999 E. Calle and et al. published the results of a cohort study, which involved more than 1 million people in the US [9]. The study found that in all groups (smokers, non-smokers, men, women, the presence or absence of chronic disease) mortality was low with BMI 22-26 kg / m2 with a small variation in the subgroups.
In multivariate analysis including age, particularly dietary habits and exercise, it was found that BMI> 30.8 kg / m2 in women decline in life expectancy observed 6.2 years (95% CI = 2.8-10, 2) compared with the same BMI in men decline was 5.9 years (95% CI 2,1-9,5) [10].
According to some large-scale prospective studies [11], overweight and obesity (BMI over 25 kg / m2) estimated to be cause of approximately 65-80% of new cases of type II diabetes.
The risk of type II diabetes is associated with the age at which the onset of obesity and what is its duration and weight gain in adulthood [12].
Some studies have estimated the number of years for which reduced life expectancy due to obesity. In the Framingham study calculated that obesity (BMI> 30 kg / m2) at age 40 is associated with a loss of 6-7 years of life [13]. Fontaine and et al. calculated that a BMI> 33 kg / m2, from the age of 40 years, is associated with a loss of 2-3 years [14]. The studies used different methods of calculation and different cohorts have been used: the basic measurements of the Framingham study belong to the 1950s, when heart disease (such as heart attacks) were associated with higher mortality than today [15].
The most concerned country about overweight among fellow citizens (more than 60% of the population) is the United States of America. Next group of countries are Germany, Great Britain and Russia. There observed that 30 to 45% of people with higher body weight. Finally, the last group of countries are Japan and China, where overweight index is only approximately 10% of the population [16].
In many countries over the past ten years, the incidence of obesity has increased an average of two times. WHO experts believe that by 2025 the number of obese patients in the world will amount to 300 million. And in 2025 the entire population of the developed countries will have some degree of obesity [17,18].
Socio-economic significance of the problem of obesity.
Overweight and obesity entails economic consequences. They include the direct costs of the health system, the indirect costs associated with the loss of economic productivity, and personal expenses such as the purchase of so-called slimming products. This chapter summarizes the main provisions of the existing literature on this issue and put some methodological issues [19]. A number of studies emphasize that obesity increases the cost of health care and the quality of life of people [20-22]. Obesity causes a range of adverse health effects associated with it such as social, psychological and economic problems affecting both the individual and society as a whole [23].
Socio-economic significance of the problem of obesity is determined by the risk of disability of patients among younger working-age population and a decrease in overall survival due to the frequent development of severe comorbidities. In 1990 Rissanen et al. found that in Finland adults with obesity often suffer from permanent disability due to cardiovascular and skeletal - muscle diseases than adults of normal weight. A study of obese people in Sweden has shown that obesity accounted for 10% loss of productivity due to temporary inability or disability [24,25].
According to studies conducted by WHO, the direct costs of medical care for obesity account for 2-4% in the total national expenditure on health. Sturm (2002), Finkelsteinetal (2005), Thorpe et al. (2004) found that health care costs for obese people about 35% higher mainly because of the high cost of treatment and associated costs [26].
For more detailed information take close look at the calculations made in the United States. It was found that compared with people of normal weight (BMI is equal to 20,0-24,9 kg / m2) against people with obesity (BMI greater than 30 kg / m2) annual health care costs were 36% higher, while people with excess (BMI is equal to 25,0-29,9 kg / m2), same expenses were up 10% higher (20). The cumulative costs of several major
diseases measured over eight years, showed a close link with BMI: for men aged 45-54 years with BMI of 22.5, 27.5, 32.5 and 37.5 kg / m2, according costs were 19 600, 24 000, 29 600 and 36 500 US dollars respectively. In fact, medical expenses throughout life may be somewhat smaller due to the premature death of obese people, but on the other hand, they may be higher in older age groups as a result of cumulative effects of long-term obesity [27,28].
An alternative approach to assess the medical expenses for the treatment of obesity requires the use of personal data. Quesenberry et al. depict an example of the model of health care organization (HMO), which estimates the cost of treating obesity in 92 US dollars per person [29].
There is another example of health care costs due to overweight in the Netherlands. In the Netherlands, the largest medical costs associated with smoking, high blood pressure and overweight (BMI greater than 25 kg / m 2). Treatment of overweight was associated with 2.0% of total health care costs, or about 1 billion Euro, whereas total health budget was 59.5 billion. Euro [30]. Also one need to focus on indirect costs, in most study for indirect costs, the slope is on assessing quantity of lost work days, and their approximate value terms [31,32]. For instance, according to calculations made in the United Kingdom, indirect costs were much higher than direct. Also, all
the estimates of obesity treating cost in England in 2002 (3.3-3.7 billion pounds) compared with data for 1998 (2.6 billion pounds)
[33]. Partly the increase in cost was due to the identification of comorbidities surveys results and other reasons were due to the increase in the cost of drugs, the more frequent reception and greater accessibility, increased costs of medical personnel and wage growth in the economy generally, as well as due to the increase in the number of obese people [33]. Data from Sweden give a similar picture; indirect costs are three times higher than the direct costs [33].
The total direct and indirect annual costs of obesity in the 15 EU countries until May 2004 were estimated at 32.8 billion euros
[34]. This figure will be even greater if we consider the data on adults with pre-obese, as well as data on the health effects in children and adolescents with increased BMI
Conclusion. In conclusion, one can say that numerous data indicate that obesity and other risk factors have economic implications. Obesity is associated with higher health care costs, at least in the short term, and higher risk of absence from work and a consequent loss of productivity.
Measures for the prevention of overweight and obesity can lead to short-term savings in health care and potentially more savings, resulting from the general increase in economic productivity.
REFERENCES
1 Samorodskaya IV. The new paradigm of obesity / / The attending physician of the medical scientific journal. - 2014. - Pp. 12-17.
2 Lazebnyk LB, Zvenigorod LA Metabolic syndrome and digestive organs. - M.: Anaharsis. - 2009. - P. 184.
3 Bessesen DG, R. Kushner Overweight and obesity: Prevention, diagnosis and treatment. - M .: ZAO "Publishing House of the BI-NOM". -2004. - Pp. 240-241.
4 Lazebnyk LB , Zvenigorod LA Metabolic syndrome and digestive organs. - M.: Anaharsis. - 2009. - P. 188
5 David B. Allison et al. Years of life lost due to obesity // JAMA. - 2003, vol. 289. - 2. - P. 187-193.
6 Makhavir Senan. The impact of obesity on cardiovascular disease: medical and socio-economic aspects of the problem // Medical science in Armenia RA NAS. - No 2, 2012. - Pp. 15-30.
7 The Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration (BMI Mediated Effects) of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1^8 million participants // Lancet. Early Online Publication, 22 November 2013 doi:10.1016/S0140-6736(13)61836-X
8 World Health Organization: Fact Sheet No.311 (May 2012). www.who.int/mediacentre/factsheets/fs311/en/
9 Calle E., Thun M.J., Petrelli J.M. et al. Body mass index and mortality in a prospective cohort of U.S. adults // N. Engl. J. Med. 1999. Vol. 341. P. 1097-1105
10 Singh P.N., Clark R.W., Herring P. et al. Obesity and Life Expectancy Among Long-Lived Black Adults // J. Gerontol. A. Biol. Sci Med. Sci. 2013. P.28
11 Seidell JC. Time trends in obesity: an epidemiological perspective // Hormone and Metabolic Research, 1997, 29 (4): pp 155-158.
12 Seidell JC. Time trends in obesity: an epidemiological perspective // Hormone and Metabolic Research, 1997, 29(4): pp160-162
13 de Lusignan S et al. A study of cardiovascular risk in overweight and obese people in England // European Journal of General Practice, 2006, 12(1):19-29.
14 Fontaine KR et al. Years of life lost due to obesity // Journal of the American Medical Association, 2003, 289(2): pp 187-193
15 Section 2 of the report, "The problem of obesity in the WHO European Region and the strategies for response" // Edited by Francesco Branca, Haik Nikogosian and Tim Lobstein. WHO, 2009. pp. 22-30
16 Jose Ramon Banegas et al. Obesity // Epidemiology, 2009, 17, p 2232-2238.
17 Dedov I.I, Melnichenko G.A. Obesity. Guide for physicians. - Mia M .: 2004, 456 s.
18 Shutova V.I., Danilova L.I. Obesity or overweight syndrome. - Medical News. - 2004. - №7. - C.49.
19 Section 3 of the report, "The problem of obesity in the WHO European Region and the strategies for response" // Edited by Francesco Branca, Haik Nikogosian and Tim Lobstein. WHO, 2009, p. 31-38
20 Keaver L., Webber L., Dee A. et al. Application of the UK Foresight Obesity Model in Ireland: The Health and Economic Consequences of Projected Obesity Trends in Ireland // PLoS One. 2013. Vol. 13;8(11):e79827. doi: 10.1371/ pp 112-138.
21 Sturm R., An R., Maroba J., Patel D. The effects of obesity, smoking, and excessive alcohol intake on healthcare expenditure in a comprehensive medical scheme // S. Afr. Med. J. 2013. Vol. 103(11). P. 840-844.
22 Zhang J., Shi X.M., Liang X.F. Economic costs of both overweight and obesity among Chinese urban and rural residents, in 2010 // Zhonghua Liu Xing Bing XueZaZhi. 2013. Vol. 34(6). P. 598-600.
23 Gema Fru..hbeck, Hermann Toplak, Euan Woodward VolkanYumuk et al. Oppert for the Executive Committee of the European Association for the Study of Obesity Obesity: The Gateway to Ill Health - an EASO Position Statement on a Rising Public Health, Clinical and Scientific Challenge in Europe / / Obes. Facts. 2013. Vol. 6. P. 117-120.
24 F. Branca, H. Nikogosian, T. Lobstein. The problem of obesity in the WHO European Region and the strategies for response // Copenhagen: WHO, 2009. 392 p.
25 Rychetnik L. et al. A glossary for evidence based public health // Journal of Epidemiology and Community Health. 2004. V. 58. P.538-545.
26 O.C. Kuznesova, A.V. Chernishev. The social and economic consequences of obesity // Bulletin of the TSU, t.19, vol.3, 2014, pp 38-57
27 Thompson D et al. Lifetime health and economic consequences of obesity //Archives of Internal Medicine, 1999, pp 159(18):2177-2183
28 Francesco Branca, Haik Nikogosian and Tim Lobstein. Section 3 of the report, "The problem of obesity in the WHO European Region and the strategies for response" // WHO, 2009, p. 31-38
29 Quesenberry CP Jr et al. Obesity, health services use, and health care costs among members of a health maintenance organization //Archives of Internal Medicine, 1998, 158(5): pp 466-472
www.kaznmu.kz В G С IН И КК,!НМ¥/*
30 Baal PHM van et al. Zorgkosten van ongezond gedrag in Nederland 2003 [Health care costs of unhealthy behaviour in the Netherlands 2003] // Bilthoven, National Institute for Public Health and the Environment, 2006 (RIVM Report 270751015) pp 121-167
31 Burton WN et al. The economic costs associated with body mass index in a workplace // Journal of Occupational and Environmental Medicine, 1998, 40 (9): pp 786-792.
32 Rissanen AM. The economic and psychosocial consequences of obesity // Ciba Foundation Symposium, 1996, 201: pp 194-201
33 House of Commons Health Committee // Obesity: third report of Session 2003-04. Volume I, report together with formal minutes. London, The Stationery Office, 2004, pp 27-94
34 Fry J., Finley W. The prevalence and costs of obesity in the EU. // Proceedings of the Nutrition Society, 2005, 64 (3): pp 359-362
С.Т. АЛЛИЯРОВА
С.Ж. Асфендияров атындагы К,азац ¥лттъщмедицина Университетi, Алматы, К^азацстан.
СЕМ1ЗД1КТЩ ЭКОНОМИКАЛЬЩ ЖЭНЕ ЭЛЕУМЕТТ1К САЛДАРЫ
tywh: Ма;алада арты; дене салмагы мен ceMi3,4iK мэселесшщ езектшш мен мен таралуы туралы эдебиет деректерi усынылады , сондай-а; семiздiк ы;пал ететш элеуметтш-экономикалы; факторлар ;арастырылады саналады. tywh сездер: артериалды; гипертония, ДД¥, семiздiк, арты; салма;.
С.Т. АЛЛИЯРОВА
Казахский Национальный медицинский университет имени С.Д.Асфендиярова г.Алматы, Казахстан
ЭКОНОМИЧЕСКИЕ И СОЦИАЛЬНЫЕ ПОСЛЕДСТВИЯ ОЖИРЕНИЯ
Резюме: В статье приводятся литературные данные об актуальности и распространенности ожирения, также рассматриваются
социально-экономические факторы способствующие к ожирению.
Ключевые слова: артериальная гипертония, ВОЗ, ожирение, избыточная масса тела
Э0Ж 616.1:616.831-053.9
к. К¥НАНБАЙ, аД. КАЙРБЕКОВ, А.Б. СЕЙДАНОВА, А.0. МЫРЗАМУРАТОВА
С.Ж.Асфендияров атындагы Цаз¥МУ
АРТЕРИЯЛЬЩ ГИПЕРТЕНЗИЯСЫ БАР НАУЦАСТАРД^Ы ИШЕМИЯЛЬЩ ИНСУЛЬТТЩ ЗАМАНАУИ
ЕМДЕУ ^ИДАЛАРЫ
Бул эдебиеттiк шолуда ишемиялыц инсульт пен артериалыц гипертензиясы бар науцастарды жyргiзу мэселеci царастырылды.Осы топ науцастарын жас жэне тyрлi бузылыстары бойынша есепке алудыц заманауи тэciлдерi керсетыген.Жогары цысымды твмендету,оптимальды децгейге келтiру,жедел инсультта антигипертензивтi терапияны тагайындау цажеттлг мен тагайындаууацыты,агрессивтшк дэрежес мэcелелерi талцытанады. Tyttmdi сездер: ишемиялыц инсульт,артериалды гипертензия,негiзгi ем.
взектШп:
Хальщаральщ популяцияльщ етгазшген тэжiрибенщ нэтижейнде жыл сайын элемде жедел ми ;анайналымыныц бузылысыныц нэтижейнде 4,7 млн адам ;айтыс болатыны дэлелдендъШыгыс Европа елдершде жалпы eлiм себебшен инсульт 2-3 орын алады.Сонымен ;атар бiр жыл iшiнде етгазшген ми за;ымынан кейiн эр 2-шi нау;ас 0мiрден етед iДД¥ берген мэлiметтерiне ;араганда,ишемиялык; инсультпен ауыратын нау;астар жалпы арнайы инсульт белiмiне госпитализацияланатын нау;астардыц шамамен 70%-ын ;урайды. ДД¥-ныц шешiмiне сэйкес ишемиялы; инсульт дегенiмiз 24 сагат бойы сак;талатын,нэтижейнде бас миыныц ишемиясына экелетiн жедел оша;ты неврологиялы; бузылыс.Ми инфаркты Yшiн неврологиялы; бузылыстардыц жылдам дамуы Yшiн ^рнеше минут,сагат немесе тэулiк шшде)тэн.Ал неврологиялы; бузылыстар жалпы милы;(ейнщ бузылуы,ЖYрек айну,;арк;ынды бас ауруы)жэне жергiлiктi бузылыстармен
(к;имыл,сезiм,сейлеу,керу,тепе-тецдiк жэне т.б бузылыстар) керiнедi.Инсульттiц ишемиялы; сипаты мен локализациясын аны;тап ;ана ;оймай,оныц этиопатогенезiн TYсiндiру ;ажет.Бул Yшiн милы; за;ым дамытатын ;ауш факторын,АГ,ЖYрек-;антамыр ЖYЙесiнiц аурулары,;ант диабетi,зиянды эдеттерi мен нау;астыц жасы (50 жастан жогары),сонымен ;атар бурын еткiзiлген
ишемиялы; инсульт жэне транзиторлы ишемиялы; шабуыл болганын аны;тап,багалау ;ажет.Ми инфаркты дамуында артериалды; гипертензия бiрден-бiр ;ауш факторы болып табылатынын айта кеткен дурыс. КР Денсаулы; са;тау министрлiгi Республикалы; гылыми-тэжiрибелiк орталыгыныц (PFT0) мэлiметтерiне ;арай,ишемиялы; инсульт бойынша госпитализацияланган нау;астардыц 75-80%-ында АГ кездесетiнi дэлелдендi. Ерте диагностика ушш жэне мидыц ишемиялы; за;ымдалган ошагын аны;тау ма;сатында нейровизуализациялы; зерттеу эдiстерi ;олданылады. КТ жэне МРТ нэтижелерш талдау барысында нау;астыц жасына, орналасуына, оша;тыц к0лемi мен санына, геморагиялы; сiцбелердiц болуына жэне тагы бас;а к0рсеткiштерге K0цiл б0лiнедi. Магнитт>резонансты ангиография ЖYргiзу кезiнде стеноздыц болуы, оклюзиясы, ульцерация немесе iрi экстра-, немесе интракраниальды артерияларга сэйкес спецификалы; атеросклерозды; емес за;ымданулардыц болуы есепке алынады. Церебралды гемодинамика туралы а;паратты брахиоцефалды артерияларды ультрадыбысты зерттеуден жэне транскраниалды доплерографиялы; эдiспен ЖYргiзу ар;ылы алуга болады.
Ми инфарктыныц келесiдей TYрге б0лiнедi: 0те жедел кезещ (инсульт басталганнан алгаш;ы 24 сагат), жедел кезецi
